CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹3.91 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹3.89 Cr |
What is the latest Contingent Liabilities ratio of CONCORD BIOTECH ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹3.91 Cr |
Mar2024 | ₹14 Cr |
Mar2023 | ₹14 Cr |
Mar2022 | ₹13 Cr |
Mar2021 | ₹3.89 Cr |
How is Contingent Liabilities of CONCORD BIOTECH Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3.91 Cr | -72.67 | |
Mar2024 | ₹14 Cr | 0.00 | |
Mar2023 | ₹14 Cr | 7.43 | |
Mar2022 | ₹13 Cr | 242.57 | |
Mar2021 | ₹3.89 Cr | - |
Compare Contingent Liabilities of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹17,586.4 Cr | -4.7% | -8.5% | 5.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,411.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | -4.7% |
-8.5% |
5.8% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses